July 21 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION ACCEPTANCE OF THE FILING OF NEW DRUG APPLICATION AND PRIORITY REVIEW FOR VOCLOSPORIN FOR THE TREATMENT OF LUPUS NEPHRITIS
* AURINIA PHARMACEUTICALS INC - FDA GRANTS PRIORITY REVIEW AND SETS PDUFA DATE OF JANUARY 22 FOR VOCLOSPORIN
* AURINIA PHARMA - FDA IS NOT PLANNING TO HOLD ADVISORY COMMITTEE MEETING TO DISCUSS APPLICATION FOR VOCLOSPORIN FOR TREATMENT OF LUPUS NEPHRITIS